secwatch.observer — SEC 8-K summary
======================================

Issuer:     GERON CORP (GERN)
CIK:        0000886744
Form:       8-K
Filed at:   2026-03-26T23:59:59+00:00
Accession:  0001193125-26-125151
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Geron elects Patricia S. Andrews and Constantine Chinoporos to board
--------------------------------------------------------------------

- Patricia S. Andrews and Constantine Chinoporos elected as Class III directors effective March 25, 2026.
- Andrews appointed to Audit Committee; terms expire at 2026 Annual Meeting.
- Andrews is former CEO of Sumitomo Pharma Oncology and global head of oncology.
- Chinoporos served as COO/CBO at Applied Therapeutics and Albireo Pharmaceuticals.
- Both will receive standard non-employee director compensation and indemnification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886744/000119312526125151/0001193125-26-125151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886744/000119312526125151/d192220d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-125151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer